<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="7971">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03003169</url>
  </required_header>
  <id_info>
    <org_study_id>ICL OBS 01</org_study_id>
    <nct_id>NCT03003169</nct_id>
  </id_info>
  <brief_title>Mastectomy in Ambulatory Breast Surgery</brief_title>
  <acronym>MASTAMBU</acronym>
  <official_title>Mastectomy in Ambulatory Breast Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Cancérologie de Lorraine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut de Cancérologie de Lorraine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective observational study, involving 550 mastectomies in Lorraine Institute
      of Oncology, to assess care patients management of ambulatory surgical compared to standard
      surgery procedure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Impact of the type of hospitalization (ambulatory / conventional) according to the type of surgery (total / partial mastectomy) on quality of life 15 days after Intervention.</measure>
    <time_frame>15 days</time_frame>
    <description>Quality of life is assessed by the EORTC QLQ-C30 questionnaire BR23</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of type of hospitalization (ambulatory / conventional) depending on the type of surgery (total / partial mastectomy) on anxiety / depression of the patient 15 days after surgery.</measure>
    <time_frame>15 days</time_frame>
    <description>Anxiety / depressions are assessed by the Hospital Anxiety and Depression scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction by type of hospitalization (ambulatory / conventional) for each type of surgery (total / partial mastectomy)</measure>
    <time_frame>15 days</time_frame>
    <description>Patient satisfaction is assessed by a satisfaction care questionnaire (PATSAT 32).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication rate within 15 days the intervention according to the type of hospitalization (ambulatory / conventional) for each type of surgery (total / partial mastectomy)</measure>
    <time_frame>15 jours</time_frame>
    <description>Postoperative complications will be classified according to Dindo- Clavien</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimate the conversion rate from ambulatory surgical to conventional surgery</measure>
    <time_frame>15 jours</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">550</enrollment>
  <condition>Mastectomy</condition>
  <arm_group>
    <arm_group_label>ambulatory surgery description</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medical questionnaire</intervention_name>
    <description>quality of life questionnaire (EORTC QLQ-C30 and QLQ-BR23)
Hospital Anxiety and Depression scale
satisfaction care questionnaire (IN-PATSAT32)</description>
    <arm_group_label>ambulatory surgery description</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The population includes all the patients managed for total or partial mastectomy at the
        institute.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient managed for breast cancer surgery

          -  age &gt;18 years old

          -  understand and comply with the requirements of the study

          -  patient must be affiliated to a social security system

        Exclusion Criteria:

          -  patient managed for a concomitant reconstructive surgery

          -  bilateral breast surgery

          -  patient already included in another clinical trial with an experimental molecule

          -  men

          -  patient deprived of liberty or under supervision

          -  neoadjuvant therapy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MARCHAL FREDERIC, MD, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut de Cancérologie de Lorraine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>GILLON VERONIQUE</last_name>
    <phone>+ 33 3 83 59 86 08</phone>
    <email>v.gillon@nancy.unicancer.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>FERNANDES LAURINDA</last_name>
    <phone>+ 33 3 83 59 84 87</phone>
    <email>l.fernandes@nancy.unicancer.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut de Cancérologie de Lorraine</name>
      <address>
        <city>Vandoeuvre</city>
        <zip>54519</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marchal Frédéreic, MD PU-PH</last_name>
      <phone>+ 33 3 83 59 84 51</phone>
      <email>f.marchal@nancy.unicancer.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 21, 2016</lastchanged_date>
  <firstreceived_date>December 21, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>surgery</keyword>
  <keyword>breast cancer</keyword>
  <keyword>quality of life</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
